Fusion of peptide epitopes to the core antigen (HBcAg) of hepatitis B virus (HBV) enhances their immunogenicity, both quantitatively and qualitatively. In a number of vaccine-induced mutants of HBV, glycine145 of the surface antigen S polypeptide (HBsAg) has been replaced by arginine, resulting in l
Effect of variation in the common ?a? determinant on the antigenicity of hepatitis B surface antigen
โ Scribed by Seddigh-Tonekaboni, Siamak; Waters, Jennifer A.; Jeffers, Sarah; Gehrke, Ralph; Ofenloch, Beatus; Horsch, Andrea; Hess, Georg; Thomas, Howard C.; Karayiannis, Peter
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 414 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
โฆ Synopsis
Antibody to the common "a" determinant of hepatitis B surface antigen (HBsAg) protects against infection with hepatitis B virus. A number of variant surface antigens with amino acid substitutions within the "a" determinant have been described in patients around the world. Both wild type and variant HBsAgs were expressed in the yeast Pichia pastoris and the antigens were semi-purified and quantitated. The effect on antigenicity of these changes was investigated in a quantitative fashion using four monoclonal antibodies known to bind to different epitopes within the common "a" determinant. The results suggest that amino acid substitution of T131I, K141E and G145R and insertion of 3 amino acids between residues 123 and 124 markedly affect the antigenic structure of HBsAg. These substitutions and insertions in the viral envelope may lead to evasion of the virus neutralizing antibody response and also to reduce efficiency of detection by immunoassays used for diagnosis and blood-bank screening.
๐ SIMILAR VOLUMES
In vitro HBV infection and neutralization were assayed using an anti-preS1 murine monoclonal antibody (1B3) and anti-preS2 (H69K) and anti-S (CS131A) murine-human chimeric antibodies. The 1B3 (IgG1) and H69K (IgG1) was constructed previously and the CS131A was constructed for this study by expressin
A chemiluminescent enzyme linked immunosorbent assay (ELISA) for the detection of antibody t o hepatitis B virus surface antigen (anti-HBs) in human serum has been developed. Polystyrene microtitre plates were coated with recombinant, yeast-derived hepatitis B surface antigen (rec-HBsAg). Patient se
The aim of this work is to study the variation of the infectious titer and the hepatitis A virus ( ) HAV antigen titer at 4, 19, and 25ะC following artificial contamination in sterile seawater. The results show that the survival of infectious HAV depends greatly on the temperature parameter. The T a